Viracta Therapeutics shares were trading lower after it said it will end an ongoing trial of Nana-val and its board has initiated a process to explore strategic options. The strategic options being ...
Diego Ordoñez explores the extraterrestrial landscape of the Dominican Republic's Cabo Rojo. Trials riding legend Dougie Lampkin drops in on the Red Bull Racing's factory to see how the team ...
Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...